Handok and Welt Begin First Prescriptions of Digital Insomnia Treatment Device 'SleepQ'

  • 2024.06.13
  • 73
Handok and Welt Begin First Prescriptions of Digital Insomnia Treatment Device 'SleepQ'

Total healthcare company Handok and digital healthcare company Welt have started prescribing the digital insomnia treatment device 'SleepQ', which they have been collaborating on. On June 12, Professor Lee Eun's team from the Department of Psychiatry at Severance Hospital prescribed SleepQ to an insomnia patient. The patient will undergo cognitive behavioral therapy for insomnia (CBT-I) implemented through digital technology for six weeks.

SleepQ is one of the first innovative medical devices to receive integrated review and approval from the Ministry of Food and Drug Safety. It collects various patient data and analyzes sleep patterns to provide personalized treatment. This allows patients to understand their sleep patterns and learn specific methods to improve insomnia symptoms.

CBT-I is a non-pharmacological treatment method recommended as the primary treatment for chronic insomnia in various countries, including the United States, Europe, Australia, and Korea. It aims to improve patients' behavior and environment through sleep restriction therapy, stimulus control therapy, cognitive restructuring, relaxation therapy, and sleep hygiene education, empowering patients to control their sleep state.

SleepQ overcomes the limitations of cognitive behavioral therapy, such as time and space constraints, thereby increasing patient participation and accessibility to treatment. Additionally, clinical trial results for SleepQ showed a significant improvement in sleep efficiency among insomnia patients. The group treated with SleepQ saw an approximately 15% increase in sleep efficiency ratio compared to the baseline at the seven-week mark. Sleep efficiency is an objective, quantitative indicator based on patient sleep data.

Currently, SleepQ is in the preparation process for prescription at some university hospitals in Korea, with full-scale prescriptions expected to begin after August.

Handok Chairman Kim YoungJin stated, "Innovation starts not from something entirely new but from finding and solving areas that need improvement. SleepQ provides improved benefits to both medical professionals and patients through digital technology and will contribute to increasing the currently very low participation rate in cognitive behavioral therapy for insomnia."

Welt CEO Kang SungJi commented, "The first patient prescription of SleepQ is a meaningful advancement. We will continue to verify the benefits and necessity of SleepQ for insomnia treatment, ensuring that digital therapeutic devices become a helpful and necessary treatment option in medical practice."
 
List
맨위로